Home > National Drug Code (NDC) > Lisinopril and Hydrochlorothiazide

Lisinopril and Hydrochlorothiazide - 65862-045-01 - (Lisinopril and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Lisinopril and Hydrochlorothiazide

Product NDC: 65862-045
Proprietary Name: Lisinopril and Hydrochlorothiazide
Non Proprietary Name: Lisinopril and Hydrochlorothiazide
Active Ingredient(s): 25; 20    mg/1; mg/1 & nbsp;   Lisinopril and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Lisinopril and Hydrochlorothiazide

Product NDC: 65862-045
Labeler Name: Aurobindo Pharma Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077606
Marketing Category: ANDA
Start Marketing Date: 20060314

Package Information of Lisinopril and Hydrochlorothiazide

Package NDC: 65862-045-01
Package Description: 100 TABLET in 1 BOTTLE (65862-045-01)

NDC Information of Lisinopril and Hydrochlorothiazide

NDC Code 65862-045-01
Proprietary Name Lisinopril and Hydrochlorothiazide
Package Description 100 TABLET in 1 BOTTLE (65862-045-01)
Product NDC 65862-045
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lisinopril and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20060314
Marketing Category Name ANDA
Labeler Name Aurobindo Pharma Limited
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 25; 20
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Lisinopril and Hydrochlorothiazide


General Information